Ledger.Open graph →

SEC Form D · filed February 7, 2022

Enalare Therapeutics Inc

Offering

$10.0M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

PRINCETON, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Gino Santini · Princeton, NJDirector Robert Yedid · Princeton, NJDirector Joseph Petko · Princeton, NJDirector Mark Coleman · Princeton, NJDirector Herman Cukier · Princeton, NJExec · Director Joseph Pergolizzi · Naples, FLExec · Director Daniel Motto · Princeton, NJExec Reena Jashnani-Slusarz · San Francisco, CAExec · Director Scott Cohen · Brooklyn, NYExec Brenden M. Smith · Mill Valley, CAExec · Director Alana Palmedo · San Francisco, CADirector Khalid Naeem · Vancouver, British Columbia, CanadaDirector Anthony Burns · Miami, FLDirector Anthony Morena · NY, NYDirector Patrick Duncan · Charleston, SCDirector David B. Rendina · Jupiter, FLExec · Director Haitham Al-Beik · MARLBOROUGH, MAExec · Director Hari Rao · MARLBOROUGH, MADirector Greg Litvak · Denver, COExec Daniel Zinn · Santa Monica, CADirector Enoch Kong · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗